Browsing Study Simulations

Displaying study simulation 126 - 150 of 579 in total
GWAS-ROCS ID Condition/Phenotype | GWAS Central ID PubMed IDSNPs (p-value)Heritability AUROC ROC Plot
GR00140Colorectal cancer | HGVRS264323300701
  • rs10879357 (3.0e-06)
0.0020.522456Gr00140
GR00326Marginal zone lymphoma | HGVRS608525569183
  • rs9461741 (4.0e-15)
  • rs2922994 (2.0e-09)
  • rs76788097 (2.0e-06)
  • rs76588427 (3.0e-06)
0.0020.522585Gr00326
GR00465Rheumatoid arthritis | HGVRS263123028356
  • rs2233434 (1.0e-15)
  • rs3125734 (5.0e-09)
0.0020.522615Gr00465
GR00123Chronic kidney disease | HGVRS113220686651
  • rs4293393 (4.0e-10)
  • rs13070584 (2.0e-06)
  • rs9310709 (2.0e-06)
  • rs10941694 (9.0e-06)
0.0020.522692Gr00123
GR00346Mortality in heart failure | HGVRS103720400778
  • rs12638540 (3.0e-07)
  • rs4528684 (1.0e-06)
  • rs2125623 (1.0e-06)
  • rs7965445 (2.0e-06)
  • rs7687921 (4.0e-06)
  • rs7120489 (7.0e-06)
  • rs4979906 (7.0e-06)
  • rs17159640 (9.0e-06)
  • (show allshow less)
0.0020.522718Gr00346
GR00234Glaucoma | HGVRS196722419738
  • rs1063192 (5.0e-11)
  • rs10483727 (9.0e-08)
  • rs7588567 (4.0e-07)
0.0020.522749Gr00234
GR00379Osteoarthritis | HGVRS128921068099
  • rs4730250 (6.0e-08)
0.0020.522851Gr00379
GR00027Alzheimer's disease | HGVRS465926049409
  • rs802571 (1.0e-06)
  • rs1992269 (1.0e-06)
  • rs11613092 (7.0e-06)
0.0020.522862Gr00027
GR00513Systemic sclerosis | HGVRS159421779181
  • rs11642873 (2.0e-12)
  • rs12540874 (1.0e-06)
  • rs11047102 (5.0e-06)
0.0020.522973Gr00513
GR00047Asthma | HGVRS453826620591
  • rs9866261 (1.0e-07)
0.0020.522979Gr00047
GR00042Arthritis (juvenile idiopathic) | HGVRS479627005825
  • rs953387 (3.0e-14)
0.0020.522995Gr00042
GR00348Mortality in heart failure | HGVRS644027149122
  • rs9885413 (3.0e-09)
  • rs12638540 (3.0e-06)
0.0020.523101Gr00348
GR00063Basal cell carcinoma | HGVRS359519151717
  • rs401681 (4.0e-12)
0.0020.523143Gr00063
GR00087Breast cancer | HGVRS178622037553
  • rs10069690 (1.0e-10)
0.0020.523852Gr00087
GR00362Multiple myeloma | HGVRS374723955597
  • rs877529 (8.0e-16)
  • rs10936599 (9.0e-14)
  • rs2285803 (1.0e-10)
  • rs4273077 (8.0e-09)
0.0020.524086Gr00362
GR00376Obesity | HGVRS154221708048
  • rs988712 (5.0e-17)
  • rs2116830 (3.0e-10)
0.0020.524314Gr00376
GR00538Type 2 diabetes | HGVRS174521874001
  • rs2028299 (2.0e-11)
  • rs7178572 (7.0e-11)
  • rs4812829 (3.0e-10)
  • rs3923113 (1.0e-08)
  • rs16861329 (3.0e-08)
  • rs1802295 (4.0e-08)
  • (show allshow less)
0.0020.52432Gr00538
GR00459Response to Dalcetrapib treatment in acute coronary syndrome | HGVRS656925583994
  • rs1967309 (2.0e-08)
0.0020.524561Gr00459
GR00080Breast cancer | HGVRS123620852631
  • rs8170 (2.0e-09)
0.0020.524669Gr00080
GR00232Gastric cancer | HGVRS654726129866
  • rs10074991 (5.0e-26)
  • rs2294693 (7.0e-08)
  • rs4578395 (2.0e-06)
0.0020.524752Gr00232
GR00305Longevity | HGVRS518024688116
  • rs4420638 (3.0e-36)
  • rs2149954 (2.0e-08)
  • rs2784505 (9.0e-06)
0.0020.524986Gr00305
GR00060Barrett's esophagus | HGVRS261422961001
  • rs9936833 (3.0e-10)
  • rs9257809 (4.0e-09)
0.0030.525059Gr00060
GR00073Bladder cancer | HGVRS65619648920
  • rs2294008 (2.0e-10)
0.0030.525216Gr00073
GR00117Cervical cancer | HGVRS598825420145
  • rs9349379 (1.0e-11)
  • rs6820391 (2.0e-08)
  • rs12402265 (2.0e-07)
  • rs11172113 (3.0e-07)
  • rs6741522 (2.0e-06)
0.0030.525536Gr00117
GR00499Survival in colorectal cancer | HGVRS541726586795
  • rs1075232 (3.0e-06)
0.0030.52562Gr00499
Displaying study simulation 126 - 150 of 579 in total